Data for Targeted Sphingolipid analysis of human Fibroblasts silenced for or overexpressing GOLPH3 (Study ST001672)

(Analysis AN002730)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3
C14_cer 0.6205 1.3179 1.0616
C14HexosylCer 0.8522 1.0135 1.1342
C14Lact-Cer NA NA NA
C14-SM 0.9151 1.0052 1.0797
C16_cer 0.5787 1.4047 1.0166
C16HexosylCer 0.7463 1.1725 1.0812
C16Lact-Cer 1.2254 0.7668 1.0078
C16-SM 0.9209 1.0482 1.0309
C18_1_cer 0.6299 1.1662 1.2039
C18_1HexosylCer 0.9456 1.0800 0.9744
C18_1Lact-Cer NA NA NA
C18_1-SM 0.9224 0.9701 1.1075
C18_cer 0.5854 1.2128 1.2018
C18HexosylCer 0.8922 1.1859 0.9219
C18Lact-Cer 1.1287 0.8358 1.0355
C18-SM 1.0136 1.0141 0.9722
C20_1_cer 0.6370 1.1550 1.2081
C20_1HexosylCer 0.9720 1.0449 0.9831
C20_1Lact-Cer NA NA NA
C20_1-SM 0.7713 1.2468 0.9819
C20_cer 0.5947 1.1712 1.2341
C20HexosylCer 0.8073 1.3946 0.7981
C20Lact-Cer NA NA 1.0000
C20-SM NA 1.0000 NA
C22_1_cer 0.5991 1.2136 1.1874
C22_1HexosylCer 0.8481 1.2179 0.9340
C22_1Lact-Cer 0.9931 1.0289 0.9780
C22_1-SM 0.9194 1.0791 1.0016
C22_cer 0.6565 1.3016 1.0419
C22HexosylCer 0.7171 1.5027 0.7802
C22Lact-Cer 1.1093 1.0565 0.8343
C22-SM 0.9043 1.1943 0.9014
C24_1_cer 0.7344 1.2686 0.9970
C24_1HexosylCer 0.8324 1.2392 0.9284
C24_1Lact-Cer 1.1784 0.9420 0.8795
C24_1-SM 0.9904 1.0320 0.9776
C24_cer 0.9087 1.2481 0.8432
C24HexosylCer 0.8140 1.3931 0.7929
C24Lact-Cer 1.2948 0.8967 0.8085
C24-SM 0.9265 1.1423 0.9312
C26_1_cer 0.8917 1.2111 0.8972
C26_1HexosylCer 0.7495 1.3362 0.9143
C26_1Lact-Cer 1.1152 1.0018 0.8830
C26_1-SM 0.7957 1.2523 0.9519
C26_cer 1.0329 1.0914 0.8757
C26HexosylCer 0.8890 1.3135 0.7975
C26Lact-Cer 1.0975 0.9883 0.9142
C26-SM 0.8754 1.2325 0.8921
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Treatment:GOLPH3 overexpression
F2Treatment:GOLPH3 silencing
F3Treatment:no treatment
  logo